The Organ Transplant Market is anticipated to grow at a CAGR of 7.8% with USD 9.1 Bn in 2026 and is expected to reach USD 17.7 Bn in 2033. Organ transplantation provides a critical treatment for patients with end-stage organ failure and can significantly extend survival while improving quality of life. Healthcare providers perform kidney, liver, heart, lung, pancreas, and intestinal transplants, supported by advances in surgical techniques, organ preservation, donor matching, and immunosuppressive therapies. In 2024, transplant centers performed a record 173,727 solid-organ transplants worldwide, demonstrating the growing importance of transplantation in modern healthcare.

Despite this progress, the organ transplant market faces a persistent supply-demand gap. The World Health Organization estimates that current transplant activity addresses less than one-tenth of global demand, with access varying widely across regions. Kidney procedures lead transplantation activity, with 110,467 kidney transplants performed in 2024, followed by 42,497 liver transplants. Rising organ failure, stronger transplant infrastructure, and expanded donation programs create opportunities, while donor shortages, regulatory hurdles, affordability, and unequal access continue to constrain the market.

Market Dynamics

Rising transplant volumes and the growing burden of organ failure are accelerating market demand. In 2024, healthcare systems performed a record 173,727 solid-organ transplants worldwide, including 110,467 kidney and 42,497 liver transplants. The shortage of available organs continues to leave substantial unmet clinical demand. As transplant centers expand capacity and refer more patients with advanced organ failure, healthcare providers increasingly require transplantation procedures, organ-preservation technologies, surgical equipment, and post-transplant therapies.

Advances in organ preservation and donor utilization are transforming transplantation practices. In 2024, deceased donors enabled 122,835 transplants, while living donors supported 50,578 procedures, highlighting the importance of both donation pathways. Donation after circulatory death also gained importance, contributing 28% of deceased-donor activity. New preservation and organ-assessment technologies allow clinicians to evaluate and utilize more marginal organs, extend preservation windows, facilitate transportation over longer distances, and reduce organ discard.

Donor shortages and unequal access continue to constrain market expansion. Despite record transplant activity, global transplantation addresses no more than one-tenth of estimated demand, while access differs significantly across regions. In 2024, the Americas performed 69,631 procedures, compared with 3,705 in the Eastern Mediterranean and 641 in Africa. Differences in donation systems, skilled workforces, infrastructure, financing, legislation, and public awareness drive these disparities. Expanding donor pools and strengthening transplant infrastructure will therefore remain critical to meeting unmet demand.

Key Features of the Study

• This report provides an in-depth analysis of the Organ Transplant Market and presents market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period 2026–2033, considering 2025 as the base year.
• It highlights potential revenue opportunities across various market segments and provides attractive investment proposition matrices for stakeholders involved in the Organ Transplant Market.
• This study offers key insights into market drivers, restraints, opportunities, transplantation technologies, organ preservation advancements, donor management, surgical innovations, immunosuppressive therapies, regional outlook, and competitive strategies adopted by leading market participants.
• It profiles key players in the Organ Transplant Market based on company overview, product portfolio, recent developments, technological advancements, financial performance, and strategic initiatives.
• Key companies covered as part of this study include Organogenesis Incorporated, Terumo Co., OrganOX, Transplant Biomedical, Preservation solution, TransMedic, WorldHeart Co., Waters Medical systems, and Jarvik Heart Incorporated.
• Insights from this report enable transplant centers, healthcare providers, medical device companies, pharmaceutical companies, investors, and management teams to make informed decisions regarding technology adoption, organ preservation investments, product development, market expansion, strategic collaborations, and transplant infrastructure development.
• The Organ Transplant Market report serves a wide range of stakeholders, including investors, hospitals, transplant centers, medical device manufacturers, pharmaceutical companies, organ procurement organizations, research institutions, technology developers, new market entrants, and financial analysts.
• Stakeholders can make well-informed strategic decisions through the analytical frameworks, competitive benchmarking, technology assessment, regional evaluation, and market opportunity matrices presented in the Organ Transplant Market report.

Market Segmentation

• By Organ Type: (Revenue, USD Bn, 2021-2033)
  • Kidney
  • Heart
  • Lungs
  • Liver
  • Intestine
  • Others
• By Region: (Revenue, USD Bn, 2021-2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
• Key Players
  • Organogenesis Incorporated
  • Terumo Co.
  • OrganOX
  • Transplant Biomedical
  • Preservation solution
  • TransMedic
  • WorldHeart Co.
  • Waters Medical systems
  • Jarvik Heart Incorporated